ArunA Bio Competitors and Similar CompaniesClear all
ArunA Bio's competitors and similar companies include Codiak Biosciences, Tmunity Therapeutics, Celularity and Eureka Therapeutics.
 ArunA Bio ArunA Bio is engaged in advancing a new class of cell-free biologics, exosomes, for the treatment of central nervous system (CNS) and neurodegenerative disorders and leveraging a platform to optimize the delivery of RNAs, antibodies, genes and small molecules. |  Codiak Biosciences Codiak Biosciences is a biopharmaceutical company focused on the development of exosome-based therapeutics. |  Tmunity Therapeutics Tmunity Therapeutics is a biotherapeutics company focused on delivering the full potential of next-generation T cell immunotherapy to patients with devastating diseases. |  Celularity Celularity is a biotechnology company developing allogeneic cells and tissues derived from the postpartum placenta. |  Eureka Therapeutics Eureka Therapeutics is a biotechnology company focused on discovery of novel antibody immunotherapies for the treatment of cancer.
| |
Founding Date | Founding Date 2003 | Founding Date 2015 | Founding Date 2015 | Founding Date 2016 | Founding Date 2006 |
Type | Type Private | Type Public | Type Private | Type Public | Type Private |
Tags | |||||
Locations | Locations Athens, US HQ Athens, US | Locations Cambridge, US HQ | Locations Philadelphia, US HQ | Locations Warren, US HQ Carlton, AU Madison, US | Locations Emeryville, US HQ |
Employees | Employees 274% increase | Employees 992% decrease | Employees 9 | Employees 1932% increase | Employees 432% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 2.8 m | Valuation ($) N/A | Valuation ($) 37.6 m | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $22.9m (FY, 2021) | Revenue (est.) N/A | Revenue (est.) $26.6m (FY, 2025) | Revenue (est.) N/A |
Net income | Net income N/A | Net income ($37.2m) (FY, 2021) | Net income N/A | Net income ($91.7m) (FY, 2025) | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round $ 4.5m (over 6 years ago) | Latest funding round N/A | Latest funding round $ 75m (over 6 years ago) | Latest funding round N/A | Latest funding round $ 45m (about 6 years ago) |
Total funding raised | Total funding raised $ 26.9m | Total funding raised $ 168.5m | Total funding raised $ 220m | Total funding raised $ 290m | Total funding raised $ 130.4m |
For sources of this data, please see the company profile
View Company Profiles
Codiak Biosciences
HQ
Cambridge, US
Employees
99↓ 2% decrease
Codiak Biosciences is a biopharmaceutical company focused on the development of exosome-based therapeutics.
View companyTmunity Therapeutics
HQ
Philadelphia, US
Employees
9
Tmunity Therapeutics is a biotherapeutics company focused on delivering the full potential of next-generation T cell immunotherapy to patients with devastating diseases.
View companyCelularity
HQ
Warren, US
Employees
193↑ 2% increase
Celularity is a biotechnology company developing allogeneic cells and tissues derived from the postpartum placenta.
View companyEureka Therapeutics
HQ
Emeryville, US
Employees
43↓ 2% decrease
Eureka Therapeutics is a biotechnology company focused on discovery of novel antibody immunotherapies for the treatment of cancer.
View company